The most recent EPS for American Shared Hospital Services is $, expectations of $-0.01.
How did American Shared Hospital Services AMS's revenue perform in the last quarter?
American Shared Hospital Services revenue for the last quarter is $
What is the revenue estimate for American Shared Hospital Services?
According to 2 of Wall street analyst, the revenue estimate of American Shared Hospital Services range from $7.93M to $7.4M
What's the earning quality score for American Shared Hospital Services?
American Shared Hospital Services has a earning quality score of B+/56.83777. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does American Shared Hospital Services report earnings?
American Shared Hospital Services next earnings report is expected in 2026-08-05
What are American Shared Hospital Services's expected earnings?
American Shared Hospital Services expected earnings is $6.93M, according to wall-street analysts.
Did American Shared Hospital Services beat earnings expectations?
American Shared Hospital Services recent earnings of $ expectations.
Key Stats
Prev.Close
--
Open
--
Day's Range
-
52 week range
-
Volume
--
Avg.Volume
107.0K
Dividend yield
--
EPS (TTM)
-0.23
Market Cap
--
What is AMS?
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment and services to healthcare providers. The company is headquartered in San Francisco, California and currently employs 82 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.